EcoDrugPlus

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSDORG00000010060
Gene Symbol: PSMA6
4 Cross references
275 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSDORG00000016684
Gene Symbol: PSMA7
4 Cross references
152 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSDORG00000009316
Gene Symbol: PSMA8
3 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSDORG00000012756
Gene Symbol: PSMB1
4 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSDORG00000002832
Gene Symbol: PSMB10
4 Cross references
172 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSDORG00000009809
Gene Symbol: PSMB3
4 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSDORG00000028831
Gene Symbol: PSMB4
3 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Beta 5

Ensembl ID : ENSDORG00000024250
Gene Symbol: PSMB5
3 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSDORG00000005851
Gene Symbol: PSMB6
4 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSDORG00000014519
Gene Symbol: PSMB7
4 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Beta 8

Ensembl ID : ENSDORG00000028592
Gene Symbol: PSMB8
4 Cross references
221 Possible Orthologues:

Proteasome 20s Subunit Beta 9

Ensembl ID : ENSDORG00000006231
Gene Symbol: PSMB9
4 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).